Outpatient Step-Up Dosing of Bispecific T-Cell Engagers
When: Friday, November 14 | 2 p.m. EST
Presenters: Tara Graff, DO, MS | Mission Cancer + Blood
As bispecific T-cell engagers (BTCEs) move from clinical trials into everyday oncology practice, more centers are adopting outpatient step-up dosing — a shift that offers patients greater access but also introduces new safety and coordination challenges.
In this session, Dr. Tara Graff shares how oncology teams can confidently transition step-up dosing to the outpatient setting with clear protocols and monitoring strategies.
Learn how to:
- Determine patient eligibility and readiness for outpatient dosing
- Structure and adjust step-up dosing schedules
- Monitor for cytokine release and early toxicities
- Build coordination between clinic and infusion staff to support safety
For additional information or login assistance, reach out to NCODA’s Jonathan Rivera.
Login to Watch this Webinar
To watch the live webinar, login to your account or register to gain access to our exclusive content.
Additional Upcoming Webinars
Upcoming Webinar
Applying the NCODA PQI: Encorafenib + Cetuximab + mFOLFOX6 for BRAF V600E–Mutated mCRC
November 6, 2025 | 2:00 PM
Upcoming Webinar
Precision Medicine in Breast Cancer – A Collaborative Approach
November 10, 2025 | 2:00 PM
Upcoming Webinar
Techs Talk Access, Safety, and Growth in Oncology Pharmacyy
November 12, 2025 | 3:00 PM